JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB174403

Recombinant Human FAAH2 protein (denatured)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human FAAH2 protein (denatured) is a Human Fragment protein, in the 32 to 532 aa range, expressed in Escherichia coli, with >80%, suitable for SDS-PAGE.

View Alternative Names

AMDD, FAAH2, Fatty-acid amide hydrolase 2, Amidase domain-containing protein, Anandamide amidohydrolase 2, Oleamide hydrolase 2

1 Images
SDS-PAGE - Recombinant Human FAAH2 protein (denatured) (AB174403)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human FAAH2 protein (denatured) (AB174403)

15% SDS-PAGE analysis of 3μg ab174403.

Key facts

Purity

>80% SDS-PAGE

Expression system

Escherichia coli

Tags

His tag N-Terminus

Applications

SDS-PAGE

applications

Biologically active

No

Accession

Q6GMR7

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 8 Constituents: 10% Glycerol (glycerin, glycerine), 2.4% Urea, 0.32% Tris HCl

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MGSSHHHHHHSSGLVPRGSHMGSGGPKFASKTPRPVTEPLLLLSGMQLAKLIRQRKVKCIDVVQAYINRIKDVNPMINGIVKYRFEEAMKEAHAVDQKLAEKQEDEATLENKWPFLGVPLTVKEAFQLQGMPNSSGLMNRRDAIAKTDATVVALLKGAGAIPLGITNCSELCMWYESSNKIYGRSNNPYDLQHIVGGSSGGEGCTLAAACSVIGVGSDIGGSIRMPAFFNGIFGHKPSPGVVPNKGQFPLAVGAQELFLCTGPMCRYAEDLAPMLKVMAGPGIKRLKLDTKVHLKDLKFYWMEHDGGSFLMSKVDQDLIMTQKKVVVHLETILGASVQHVKLKKMKYSFQLWIAMMSAKGHDGKEPVKFVDLLGDHGKHVSPLWELIKWCLGLSVYTIPSIGLALLEEKLRYSNEKYQKFKAVEESLRKELVDMLGDDGVFLYPSHPTVAPKHHVPLTRPFNFAYTGVFSALGLPVTQCPLGLNAKGLPLGIQVVAGPFNDHLTLAVAQYLEKTFGGWVCPGKF","proteinLength":"Fragment","predictedMolecularWeight":"57.4 kDa","actualMolecularWeight":null,"aminoAcidEnd":532,"aminoAcidStart":32,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q6GMR7","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FAAH2 (Fatty Acid Amide Hydrolase 2) is an enzyme that breaks down fatty acid amides. FAAH2 shows structural similarity to FAAH but has distinct substrate specificity. The approximate molecular mass of FAAH2 is 63 kDa. It is widely expressed in several human tissues including the brain liver and kidneys among others. Understanding FAAH2's mechanical role can offer insights into its biological functions and applications in research.
Biological function summary

FAAH2 acts in regulating lipid signaling pathways by hydrolyzing bioactive fatty acid amides. Unlike FAAH FAAH2 appears less efficient in degrading some endocannabinoids suggesting a unique role in signaling processes. It does not function as part of a larger protein complex but its activity results in bioactive lipids important for various cellular responses. This regulation helps maintain cellular lipid balance and influences cellular communication.

Pathways

FAAH2 participates in the endocannabinoid and lipid signaling pathways. It helps modulate local levels of fatty acid amides affecting synaptic plasticity and pain perception. FAAH2 is related to proteins like FAAH through shared involvement in these pathways which manage neurotransmitter release and reception. Understanding FAAH2's placement and function within these pathways can help in designing new therapeutic approaches.

FAAH2 shows potential links to neurological conditions and metabolic disorders. Altered FAAH2 activity may contribute to mood disorders due to its role in endocannabinoid regulation. FAAH2 also has a potential relationship with obesity where altered lipid signaling disrupts energy balance. FAAH closely associated with FAAH2 might share overlapping physiological roles that could influence disease outcomes when FAAH2 function is disrupted. Research into the links of FAAH2 with disorders provides avenues for targeted therapies.

Specifications

Form

Liquid

General info

Function

Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules (PubMed : 17015445, PubMed : 19926788). Hydrolyzes monounsaturated substrate anandamide preferentially as compared to polyunsaturated substrates.

Sequence similarities

Belongs to the amidase family.

Product protocols

Target data

Catalyzes the hydrolysis of endogenous amidated lipids like the sleep-inducing lipid oleamide ((9Z)-octadecenamide), the endocannabinoid anandamide (N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine), as well as other fatty amides, to their corresponding fatty acids, thereby regulating the signaling functions of these molecules (PubMed : 17015445, PubMed : 19926788). Hydrolyzes monounsaturated substrate anandamide preferentially as compared to polyunsaturated substrates.
See full target information FAAH2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com